A Phase 4 interventional study of dexmedetomidine in Abnormal Menstrual Cycle, sponsored by Fudan University. Completed. Open to female participants aged 24 Years to 40 Years. Per ClinicalTrials.gov, last updated 2014-01-14.
Sponsored by Fudan University · Phase 4, Interventional, and Prevention
The study was done to evaluate the effects of the follicular and luteal phases of the menstrual cycle on sedation level at loss of consciousness and bispectral index reach to 50 during propofol anesthesia, in patients with and without preoperative intravenous dexmedetomidine .
Fudan University is the lead sponsor of 1,270 studies on the registry; 623 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Drug: dexmedetomidine
bispectral index at loss of eyelash reflex
Time frame: up to 2 years
propofol requirements from propofol administered to loss of eyelash reflex and bispectral index reduced to 50
Time frame: up to 2 years
duration from propofol administered to loss of eyelash reflex and bispectral index reduced to 50
Time frame: up to 2 years
No study locations are listed for this record.
This study is completed, as verified in Jan 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Fudan University